STOCK TITAN

Rockwell Medical (RMTI) SVP awarded 15,000 RSUs after 1-for-10 split

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Chole Timothy reported acquisition or exercise transactions in this Form 4 filing.

ROCKWELL MEDICAL, INC. granted SVP and CCO Timothy Chole 15,000 shares of Common Stock as a compensation award, recorded at $0.00 per share. These restricted stock units vest in three equal installments on the first, second and third anniversaries of July 1, 2026, contingent on his continued service.

The company effected a 1-for-10 reverse split of its common stock effective at 12:01 AM on July 1, 2026. Following the grant and split adjustment, Chole beneficially owns 27,285 shares of Rockwell Medical common stock directly.

Positive

  • None.

Negative

  • None.
Insider Chole Timothy
Role SVP and CCO
Type Security Shares Price Value
Grant/Award Common Stock 15,000 $0.00 --
Holdings After Transaction: Common Stock — 27,285 shares (Direct, null)
Footnotes (1)
  1. Restricted stock units ("RSUs") vest in three equal installments on the first, second and third anniversaries of July 1, 2026, subject to the Reporting Person's continued service to the Issuer. Effective at 12:01 AM on July 1, 2026, the Issuer effected a 1-for-10 reverse split of the Issuer's common stock resulting in a reduction in the number of shares held by the Reporting Person. In addition, proportionate adjustments were made to the Issuer's outstanding equity awards. Accordingly, the shares listed under Amount of Securities Beneficially Owned Following Reported Transaction(s) reported in this Form 4 have been adjusted to reflect the 1-for-10 reverse split.
Stock grant size 15,000 shares Common Stock grant to Timothy Chole on July 1, 2026
Grant price $0.00 per share Compensation award, not open-market purchase
Post-transaction holdings 27,285 shares Shares beneficially owned following reported transaction(s)
Reverse split ratio 1-for-10 Reverse split effective 12:01 AM on July 1, 2026
Vesting schedule 3 equal installments RSUs vest on 1st, 2nd, 3rd anniversaries of July 1, 2026
Restricted stock units ("RSUs") financial
"Restricted stock units ("RSUs") vest in three equal installments"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
reverse split financial
"the Issuer effected a 1-for-10 reverse split of the Issuer's common stock"
A reverse split is when a company reduces the number of its outstanding shares by combining several existing shares into one new share, so the price per share rises proportionally while the company’s overall value stays the same. Investors care because it can make a stock appear more respectable or meet exchange rules — like turning many small coins into a single larger bill — but it can also signal financial trouble and often affects trading liquidity and investor perception.
equity awards financial
"proportionate adjustments were made to the Issuer's outstanding equity awards"
Equity awards are payments to employees or directors made in the form of company stock or rights to buy stock later, serving as a way to share ownership rather than cash. For investors, they matter because they align staff incentives with company performance, can increase the number of shares outstanding over time (which can reduce each share’s claim on profits), and create compensation costs that affect reported earnings.
Amount of Securities Beneficially Owned Following Reported Transaction(s) financial
"the shares listed under Amount of Securities Beneficially Owned Following Reported Transaction(s)"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What did Rockwell Medical (RMTI) disclose about Timothy Chole in this Form 4?

Rockwell Medical reported a stock grant to SVP and CCO Timothy Chole. He received 15,000 shares of common stock as a compensation award, with the filing also updating his post-transaction holdings and reflecting a recent 1-for-10 reverse stock split.

How many Rockwell Medical (RMTI) shares were granted to Timothy Chole?

Timothy Chole was granted 15,000 shares of Common Stock. The transaction is coded as a grant or award acquisition at a price of $0.00 per share, representing restricted stock units that vest over time rather than an open-market stock purchase.

When do Timothy Chole’s Rockwell Medical (RMTI) RSUs vest?

The RSUs vest in three equal annual installments. Vesting occurs on the first, second, and third anniversaries of July 1, 2026, provided Chole continues to serve the company, aligning the award with ongoing executive service and retention objectives.

What is Timothy Chole’s Rockwell Medical (RMTI) shareholding after this transaction?

After the reported transaction, Chole beneficially owns 27,285 shares. This figure reflects adjustments from Rockwell Medical’s 1-for-10 reverse stock split and includes the effect of the newly granted restricted stock units reported in the Form 4.

How did Rockwell Medical’s (RMTI) 1-for-10 reverse split affect this Form 4?

The reverse split reduced the number of shares outstanding and adjusted awards. Effective July 1, 2026, the 1-for-10 reverse split led to proportionate changes to outstanding equity awards, including the amount of securities beneficially owned reported for Timothy Chole.

Was Timothy Chole’s Rockwell Medical (RMTI) transaction an open-market buy or sale?

No, it was a compensation grant rather than a market trade. The Form 4 shows transaction code “A” for a grant, award, or other acquisition at $0.00 per share, indicating stock-based compensation instead of an open-market purchase or sale.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Chole Timothy

(Last)(First)(Middle)
30142 WIXOM ROAD

(Street)
WIXOM MICHIGAN 48393

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
ROCKWELL MEDICAL, INC. [ RMTI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
SVP and CCO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/01/2026A(1)15,000A$027,285(2)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Restricted stock units ("RSUs") vest in three equal installments on the first, second and third anniversaries of July 1, 2026, subject to the Reporting Person's continued service to the Issuer.
2. Effective at 12:01 AM on July 1, 2026, the Issuer effected a 1-for-10 reverse split of the Issuer's common stock resulting in a reduction in the number of shares held by the Reporting Person. In addition, proportionate adjustments were made to the Issuer's outstanding equity awards. Accordingly, the shares listed under Amount of Securities Beneficially Owned Following Reported Transaction(s) reported in this Form 4 have been adjusted to reflect the 1-for-10 reverse split.
Remarks:
/s/ Megan Timmins, Attorney-in-fact for Timothy Chole07/06/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)